Overview
Semax Overview
Semax is a synthetic heptapeptide built on the ACTH(4-7) fragment (Met-Glu-His-Phe) joined to a C-terminal Pro-Gly-Pro tripeptide. It is commonly described as an analog of the adrenocorticotropic hormone fragment ACTH(4-10). The full sequence is Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP), seven residues in total.
The Pro-Gly-Pro extension slows exopeptidase cleavage, which makes Semax a stable reference compound at the bench. It lacks the corticotropic activity of the parent fragment. In vitro and preclinical laboratory models have used it to examine BDNF and NGF transcript and protein readouts, TrkB receptor signaling, monoaminergic pathway activity, enkephalin-degrading enzyme and aminopeptidase inhibition assays, and gene and protein expression profiling in neuronal tissue preparations. It is also used as an analytical reference in HPLC and mass spectrometry method development.
Each lot is made by solid-phase peptide synthesis, third-party tested, and supplied with a Certificate of Analysis.
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP) |
|---|---|
| Sequence length | 7 residues |
| Also known as | ACTH(4-7)-PGP, ACTH(4-10) analog, Pro-Gly-Pro-ACTH, MEHFPGP |
| Molecular formula | C37H51N9O10S |
| Molecular weight | 813.92 g/mol |
| CAS number | 80714-61-0 |
| PubChem CID | 9811102 |
| Form | Lyophilized powder |
| Purity | ≥99% by HPLC, per COA |
| Storage | -20°C, sealed and protected from light |
Certificate of Analysis
| Date | Lot | Certificate |
|---|---|---|
| Semax - 10mgApr 24, 2026 | 26102302 | View COA |